Medicare

Annual Medicare Expense for Anti-VEGF Injections Tops $4 Billion, Study Finds

A significant rise ($1.5 billion more per year) can be attributed to greater uptake of aflibercept by retina specialists. Regional differences reflect local variation in disease burden.
02/21/2024

Age-related Eye Diseases Higher in Prevalence, Incidence Over 15 Years

While the trends reported represent small changes, due to the size of the US Medicare beneficiary population these differences equate to a large number of individuals and considerable economic cost.
07/26/2023

Lack of Eye Care Access in US Reflects Socioeconomic Trends

Patients with Medicare in areas that were rural, had lower household incomes or higher unemployment rates did not make significant use of available services.
05/30/2023

Upcoming Events

December 5, 2024

Rethinking Dry Eye Disease: A Contemporary Approach to a Complex Condition
Location: Virtual
Presenters: Nate Lighthizer, OD, and Dagny Zhu, MD
Webinar: 9:00pm ET

Sponsored by Bausch + Lomb

Register here

December 6-7, 2024

West Coast Optometric Glaucoma Symposium
Location: Westin Carlsbad, Carlsbad, California
Program Co-Chairs: Murray Fingeret, OD, and Robert N. Weinreb, MD
Earn up to 12 LIVE COPE Credits (accreditation pending)

Register here

December 7-8, 2024

Retina Update 2024
Location: Westin Carlsbad, Carlsbad, California
Program Chairs: Mohammad Rafieetary, OD, and Steven Ferrucci, OD
Earn up to 11 LIVE COPE credits (accreditation pending)

Register here